Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.
Press releases published on August 15, 2025
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market
GlobeNewswire
·
August 15, 2025
SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate, the company’s innovative stem cell-derived therapy, which has already …
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 15, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …
Sienna Announces August Dividend
GlobeNewswire
·
August 15, 2025
MARKHAM, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of August 2025, representing $0 …
Global Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 15, 2025
Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Innovations in supply chain management and the rise of direct-to-patient models are transforming how life sciences companies execute global clinical trials. The global clinical trial supplies market, …
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies
GlobeNewswire
·
August 15, 2025
Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increased demand for drug …
Global Digital Pathology Market to Reach $13.7 Billion in 2029
GlobeNewswire
·
August 15, 2025
Boston, Aug. 15, 2025 (GLOBE NEWSWIRE) -- As global demand for precision diagnostics rises, digital pathology is reshaping how clinical labs, research institutions, and healthcare systems operate. From AI-assisted image analysis to remote pathology …
Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split
GlobeNewswire
·
August 15, 2025
FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that …
Stryker to host investor day
GlobeNewswire
·
August 15, 2025
Portage, Michigan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Investor Day on Thursday, November 13, 2025, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A live audio webcast of the session, along with a replay, …
Global Wound Care Market Set to Surpass USD 30.48 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 15, 2025
Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Growing demand for advanced wound management solutions meets innovation and strategic expansion across global healthcare systems The global wound care market, valued at US$20.97 billion in 2024, stood at …
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
GlobeNewswire
·
August 15, 2025
HOUSTON, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) …
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 15, 2025
Patient enrollment for our ongoing Phase-3 clinical trial of SGT-610 for Gorlin Syndrome has been completed; top-line results are expected in the fourth quarter of 2026 Phase-1b proof-of-concept clinical trial of SGT-210 for Darier disease is ongoing Sol- …
Medical Tubing Market worth $18.41 billion by 2030, at a CAGR of 8.0%, says MarketsandMarkets™
GlobeNewswire
·
August 15, 2025
Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Medical Tubing Market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period. The market for medical tubing is expanding swiftly …
To “Eat” or to “Escape”? NTHU Uncovers Olfactory Code of Fruit Fly Brain
GlobeNewswire
·
August 15, 2025
HSINCHU, Taiwan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Director of the Brain Research Center at National Tsing Hua University (NTHU) in Taiwan, Ann-Shyn Chiang (江安世), Professor of the Institute for Systems Neuroscience, Chung-Chuan Lo (羅中泉), and …
EAACI startet globale Aufklärungskampagne zu Antibiotikaallergien auf dem EAACI-Kongress 2025 (EAACI Congress 2025)
GlobeNewswire
·
August 15, 2025
ZÜRICH, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Die EAACI hat im Rahmen ihres Kongresses 2025 in Glasgow ihre Aufklärungskampagne zum Thema Antibiotikaallergien gestartet. Die Initiative ist der Beginn einer weltweiten Kampagne gegen falsche Kennzeichnung und …
L’EAACI lance une campagne mondiale de sensibilisation aux allergies aux antibiotiques lors du EAACI Congress 2025
GlobeNewswire
·
August 15, 2025
ZURICH, 15 août 2025 (GLOBE NEWSWIRE) -- L’EAACI a lancé sa Antibiotic Allergy Awareness Campaign (Campagne de sensibilisation aux allergies aux antibiotiques) à l’occasion de son Congrès 2025 à Glasgow. Cette initiative marque le début d’un effort mondial …
La EAACI lanza campaña mundial de concienciación sobre la alergia a los antibióticos en el Congreso de la EAACI 2025 (EAACI Congress 2025)
GlobeNewswire
·
August 15, 2025
ZÚRICH, Aug. 15, 2025 (GLOBE NEWSWIRE) -- La EAACI lanzó la campaña de concienciación sobre la alergia a los antibióticos en el marco de su congreso de 2025 celebrado en Glasgow. La iniciativa da comienzo a un esfuerzo mundial por responder al etiquetado …
EAACI משיקה קמפיין מודעות עולמי לאלרגיה לאנטיביוטיקה בקונגרס EAACI 2025
GlobeNewswire
·
August 15, 2025
ציריך, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI השיקה את קמפיין המודעות לאלרגיה לאנטיביוטיקה במהלך הקונגרס שלה לשנת 2025 בגלזגו. היוזמה מתחילה במאמץ עולמי לטפל בתיוג שגוי והקשר שלו לעמידות אנטי-מיקרוביאלית (AMR). קריאה גלובלית לפעולה תיוג שגוי של אלרגיה …
EAACI Meluncurkan Kampanye Peningkatan Kesadaran Alergi Antibiotik Global di Kongres EAACI 2025 (EAACI Congress 2025)
GlobeNewswire
·
August 15, 2025
ZURICH, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI telah meluncurkan Kampanye Peningkatan Kesadaran Alergi Antibiotiknya selama Kongres 2025 di Glasgow. Inisiatif ini memulai upaya global untuk mengatasi kesalahan pelabelan dan kaitannya dengan resistensi …
EAACI、2025年度EAACI会議 (EAACI Congress 2025) で、世界規模の抗生物質アレルギー意識向上キャンペーンを開始
GlobeNewswire
·
August 15, 2025
チューリッヒ発, Aug. 15, 2025 (GLOBE NEWSWIRE) -- 欧州アレルギー・臨床免疫学会 (European Academy of Allergy and Clinical Immunology、EAACI) は、グラスゴーでの2025年度EAACI会議において、抗生物質アレルギー意識向上キャンペーンを開始した。 このイニシアチブでは、誤表示と薬剤耐性 (AMR) へのその関連性に対処するために世界規模の取り組みを開始する。 世界的な行動の呼びかけ …
EAACI, 2025 EAACI 학회에서 전 세계 항생제 알레르기 인식 제고 캠페인 개시
GlobeNewswire
·
August 15, 2025
취리히, Aug. 15, 2025 (GLOBE NEWSWIRE) -- 유럽 알레르기 임상 면역학회 (EAACI)가 2025년 글래스고에서 열린 학회에서 ‘항생제 알레르기 인식 제고 캠페인’ (Antibiotic Allergy Awareness Campaign) 을 시작했다. 이번 이니셔티브는 잘못된 표기와 항균제 내성(AMR) 간의 연관성을 해결하기 위한 전 세계적 노력이 시작됨을 알리는 행보이다. 전 세계적 행동 촉구에 나서다 항생제 알레르기 오표기는 …